Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MITF | O75030 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4281573 | 0.96 | L3MBTL1 (0.49) | GRM4SMN1; SMN2ALDH1A1KDM4EHTT | |
| SCHEMBL4293142 | 0.90 | ALDH1A1 (0.51) | SMN1; SMN2ALDH1A1KDM4EHTTKMT2A | |
| SCHEMBL4281447 | 0.87 | TSHR (0.51) | SMN1; SMN2ALDH1A1EPHX2KDM4EKMT2A | |
| SCHEMBL4286877 | 0.85 | PAX8 (0.56) | SMN1; SMN2ALDH1A1KDM4EHTTKMT2A | |
| SCHEMBL4279961 | 0.85 | KMT2A (0.51) | SMN1; SMN2ALDH1A1EPHX2KDM4EKMT2A | |
| SCHEMBL4285745 | 0.85 | GRM5 (0.43) | SMN1; SMN2ALDH1A1HTTKMT2AL3MBTL1 | |
| SCHEMBL4279807 | 0.84 | SMN1; SMN2 (0.49) | GRM4SMN1; SMN2ALDH1A1KDM4EHTT | |
| SCHEMBL4287145 | 0.83 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1EPHX2KDM4EHTT | |
| SCHEMBL4279912 | 0.83 | KMT2A (0.51) | SMN1; SMN2ALDH1A1KDM4EHTTKMT2A | |
| SCHEMBL4279804 | 0.83 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1EPHX2KDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156582-A1 | Pyrazole Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-18 | — | — | US | disclosed |
| EP-1847531-A1 | PYRAZOLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2007-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156582-A1 | Pyrazole Compound | GSK3B, GSK3A, GSKIP | GRM4 4042/4885SMN1; SMN2 4064/4885ALDH1A1 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.